Technical Analysis for BASI - Bioanalytical Systems, Inc.
|Grade||Last Price||% Change||Price Change|
BASI closed up 5.19 percent on Friday, January 18, 2019, on 25 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
|Weak or Absent||Down||Up||Up|
|See historical BASI trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||180 Bullish Setup||Bullish Swing Setup||0.00%|
|Jan 18||Calm After Storm||Range Contraction||0.00%|
|Jan 18||Narrow Range Bar||Range Contraction||0.00%|
|Jan 18||NR7||Range Contraction||0.00%|
|Jan 18||Upper Bollinger Band Walk||Strength||0.00%|
|Jan 18||Inside Day||Range Contraction||0.00%|
|Jan 18||Above Upper BB||Strength||0.00%|
|Jan 17||MACD Bullish Centerline Cross||Bullish||5.19%|
|Jan 17||Upper Bollinger Band Touch||Strength||5.19%|
|Jan 16||Crossed Above 50 DMA||Bullish||-1.39%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Bioanalytical Systems, Inc. provides drug discovery and development services for pharmaceutical, biotechnology, academic, and government organizations in North America, the Pacific Rim, Europe, and internationally. It operates in two segments, Contract Research Services and Research Products. The Contract Research Services segment offers various services, including product characterization, method development, and validation; bioanalytical testing to measure drug and metabolite concentrations in complex biological matrices; stability testing to establish and confirm product purity, potency, and shelf life; in vivo sampling services for the continuous monitoring of chemical changes in life; and pharmacokinetic and safety testing services, as well as provides screening and pharmacological testing, preclinical safety testing, formulation development, regulatory compliance, and quality control testing services. The Research Products segment offers analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments; and Vetronics' products, such as instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more BASI news...
|52 Week High||2.59|
|52 Week Low||1.18|
|200-Day Moving Average||1.5688|
|50-Day Moving Average||1.3432|
|20-Day Moving Average||1.3094|
|10-Day Moving Average||1.3299|
|Average True Range||0.067|
|Chandelier Exit (Long, 3 ATRs )||1.239|
|Chandelier Exit (Short, 3 ATRs )||1.381|
|Upper Bollinger Band||1.4086|
|Lower Bollinger Band||1.2102|
|Percent B (%b)||1.06|
|MACD Signal Line||-0.008|
|Market Cap||11.7 Million|
|Num Shares||8.24 Million|
|Price-to-Earnings (P/E) Ratio||-8.35|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||1.44|
|Resistance 3 (R3)||1.43||1.43||1.43|
|Resistance 2 (R2)||1.43||1.42||1.43||1.43|
|Resistance 1 (R1)||1.42||1.42||1.43||1.43||1.43|
|Support 1 (S1)||1.41||1.41||1.42||1.42||1.41|
|Support 2 (S2)||1.41||1.41||1.41||1.41|
|Support 3 (S3)||1.40||1.41||1.41|
|Support 4 (S4)||1.41|